Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC6A14 |
| Upstream (Parents) |
|---|
| (<<) CAV3 → SLC6A14 |
| (<<) CDK6 → SLC6A14 |
| (<<) CITED4 → SLC6A14 |
| (<<) CMTM7 → SLC6A14 |
| (<<) CNIH4 → SLC6A14 |
| (<<) CORO6 → SLC6A14 |
| (<<) DKFZP434I0714 → SLC6A14 |
| (<<) ELF5 → SLC6A14 |
| (<<) EPHA4 → SLC6A14 |
| (<<) EPHB3 → SLC6A14 |
| (<<) FUT4 → SLC6A14 |
| (<<) FZD7 → SLC6A14 |
| (<<) GRK5 → SLC6A14 |
| (<<) HYAL1 → SLC6A14 |
| (<<) ILDR1 → SLC6A14 |
| (<<) ITGA6 → SLC6A14 |
| (<<) KCNN4 → SLC6A14 |
| (<<) KHDRBS3 → SLC6A14 |
| (<<) KLK5 → SLC6A14 |
| (<<) KLK7 → SLC6A14 |
| (<<) KRT6B → SLC6A14 |
| (<<) LEMD1 → SLC6A14 |
| (<<) LIPG → SLC6A14 |
| (<<) LYPLA2 → SLC6A14 |
| (<<) MLX → SLC6A14 |
| (<<) NFATC1 → SLC6A14 |
| (<<) PHLDA1 → SLC6A14 |
| (<<) PRKCD → SLC6A14 |
| (<<) PTGS2 → SLC6A14 |
| (<<) RASD1 → SLC6A14 |
| (<<) RPS12 → SLC6A14 |
| (<<) SERPINB5 → SLC6A14 |
| (<<) SGK1 → SLC6A14 |
| (<<) SLC25A37 → SLC6A14 |
| (<<) SOCS3 → SLC6A14 |
| (<<) TNFRSF11A → SLC6A14 |
| (<<) TNRC18 → SLC6A14 |
| (<<) UGDH → SLC6A14 |
| Downstream (Children) |
|---|
| SLC6A14 → CEACAM1 (>>) |
| SLC6A14 → FOXC2 (>>) |
